CHRISTINE POSSEMATO: Open Payments
NPI 1053680413 · FREEHOLD, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$746 in 29 payments from 9 companies in 2025. Trend: 2023 $703 · 2024 $792 · 2025 $746
Food & beverage: $746
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 8 | $303 |
| Janssen Pharmaceuticals, Inc | 9 | $169 |
| Indivior Inc. | 1 | $78 |
| ABBVIE INC. | 4 | $63 |
| Neurocrine BioSciences, Inc. | 2 | $45 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $36 |
| Alkermes, Inc. | 1 | $18 |
| E.R. Squibb & Sons, L.L.C. | 1 | $18 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
Products named: UZEDY, INVEGA SUSTENNA, SUBLOCADE, VRAYLAR, SPRAVATO, INGREZZA, AUSTEDO XR, CAPLYTA.
Industry payments across NJ — which companies pay providers there.
